H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 45 Citations 7,455 80 World Ranking 2647 National Ranking 165

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Malaria
  • Immune system

Malaria, Plasmodium falciparum, Pediatrics, Malaria vaccine and RTS,S are his primary areas of study. The concepts of his Malaria study are interwoven with issues in Adverse effect and Randomized controlled trial. His Plasmodium falciparum study combines topics from a wide range of disciplines, such as Internal medicine and Pharmacology.

Saadou Issifou combines subjects such as Incidence and Vaccination with his study of Malaria vaccine. His Vaccination research incorporates elements of Circumsporozoite protein and Vaccination schedule. He has researched Immunology in several fields, including Pregnancy and Low birth weight.

His most cited work include:

  • First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (684 citations)
  • First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (684 citations)
  • Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. (568 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Malaria, Plasmodium falciparum, Immunology, Pediatrics and Internal medicine. His Malaria research is multidisciplinary, incorporating perspectives in Adverse effect, Surgery and Incidence. His Plasmodium falciparum research integrates issues from Virology, Clindamycin, Asymptomatic, Antibody and Pharmacology.

His Pediatrics research incorporates themes from Tropical medicine, Severe Malaria, Randomized controlled trial and Clinical trial. His work in Internal medicine addresses issues such as Parasitemia, which are connected to fields such as Anemia. As a part of the same scientific study, he usually deals with the Malaria vaccine, concentrating on Vaccination and frequently concerns with RTS,S and Immunization.

He most often published in these fields:

  • Malaria (103.80%)
  • Plasmodium falciparum (80.38%)
  • Immunology (55.06%)

What were the highlights of his more recent work (between 2012-2021)?

  • Immunology (55.06%)
  • Malaria vaccine (23.42%)
  • Malaria (103.80%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Immunology, Malaria vaccine, Malaria, Pediatrics and Plasmodium falciparum. His Malaria vaccine research is multidisciplinary, incorporating elements of Antibody, Incidence and Virology. His Incidence study incorporates themes from Meningitis, Booster dose and RTS,S.

His Malaria research includes themes of Internal medicine, Adverse effect, Risk factor and Surgery. His research in Pediatrics intersects with topics in Prospective cohort study, Randomized controlled trial, Cerebral Malaria and Artesunate. The concepts of his Plasmodium falciparum study are interwoven with issues in Pregnancy and Immune system, Vaccine efficacy, Immunogenicity.

Between 2012 and 2021, his most popular works were:

  • Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. (568 citations)
  • Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria—A Double-center Prospective Study (56 citations)
  • A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. (50 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Malaria
  • Immune system

His main research concerns Malaria vaccine, Malaria, Immunology, Plasmodium falciparum and Pediatrics. His Malaria vaccine study combines topics from a wide range of disciplines, such as Incidence and Avidity. His Malaria research integrates issues from Sickle cell trait, Adverse effect, Prospective cohort study and Haemolysis.

As a part of the same scientific family, Saadou Issifou mostly works in the field of Adverse effect, focusing on Artesunate and, on occasion, Surgery. His work carried out in the field of Plasmodium falciparum brings together such families of science as Vaccination, Virology and Immunoglobulin G, Antibody, Immunogenicity. The study incorporates disciplines such as Booster dose, Randomized controlled trial, RTS,S and PfSPZ vaccine in addition to Pediatrics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;Solange Solmeheim Soulanoudjingar;Solange Solmeheim Soulanoudjingar.
The New England Journal of Medicine (2011)

1077 Citations

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Emmanuel B. Bache;Selidji Todagbe Agnandji;Bertrand Lell;José Francisco Fernandes.
The Lancet (2015)

869 Citations

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Selidji Todagbe Agnandji;Selidji Todagbe Agnandji;Bertrand Lell;Bertrand Lell;José Francisco Fernandes;José Francisco Fernandes.
The New England Journal of Medicine (2012)

550 Citations

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

John J Aponte;David Schellenberg;Andrea Egan;Alasdair Breckenridge.
The Lancet (2009)

271 Citations

Fosmidomycin for malaria

Michel A Missinou;Steffen Borrmann;Steffen Borrmann;Andreas Schindler;Andreas Schindler;Saadou Issifou;Saadou Issifou.
The Lancet (2002)

267 Citations

Fosmidomycin-Clindamycin for the Treatment of Plasmodium falciparum Malaria

Steffen Borrmann;Steffen Borrmann;Saadou Issifou;Saadou Issifou;Gilbert Esser;Gilbert Esser;Ayola A. Adegnika;Ayola A. Adegnika.
The Journal of Infectious Diseases (2004)

175 Citations

Placental Malaria Increases Malaria Risk in the First 30 Months of Life

Norbert G. Schwarz;Norbert G. Schwarz;Ayola A. Adegnika;Ayola A. Adegnika;Ayola A. Adegnika;Lutz P. Breitling;Lutz P. Breitling;Julian Gabor;Julian Gabor.
Clinical Infectious Diseases (2008)

161 Citations

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante;Salim Abdulla;Selidji Agnandji;Selidji Agnandji;John Lyimo.
Lancet Infectious Diseases (2011)

155 Citations

Fosmidomycin-Clindamycin for Plasmodium falciparum Infections in African Children

Steffen Borrmann;Ayola A. Adegnika;Pierre-Blaise Matsiegui;Saadou Issifou;Saadou Issifou.
The Journal of Infectious Diseases (2004)

145 Citations

Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight.

Ayôla A. Adegnika;Jaco J. Verweij;Selidji T. Agnandji;Sanders K. Chai.
American Journal of Tropical Medicine and Hygiene (2006)

144 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Saadou Issifou

Peter G. Kremsner

Peter G. Kremsner

University of Tübingen

Publications: 195

James G. Beeson

James G. Beeson

Burnet Institute

Publications: 106

Martin P. Grobusch

Martin P. Grobusch

University of Amsterdam

Publications: 84

Benjamin Mordmüller

Benjamin Mordmüller

Radboud University Medical Center

Publications: 79

Ayola A. Adegnika

Ayola A. Adegnika

University of Tübingen

Publications: 78

Marcel Tanner

Marcel Tanner

Swiss Tropical and Public Health Institute

Publications: 61

Michael Theisen

Michael Theisen

Statens Serum Institut

Publications: 54

Pedro L. Alonso

Pedro L. Alonso

University of Barcelona

Publications: 51

Adrian V. S. Hill

Adrian V. S. Hill

University of Oxford

Publications: 51

Brian Greenwood

Brian Greenwood

London School of Hygiene & Tropical Medicine

Publications: 50

Freya J. I. Fowkes

Freya J. I. Fowkes

Burnet Institute

Publications: 50

Robert W. Sauerwein

Robert W. Sauerwein

Radboud University Nijmegen

Publications: 40

Ivo Mueller

Ivo Mueller

Walter and Eliza Hall Institute of Medical Research

Publications: 37

Philip Bejon

Philip Bejon

University of Oxford

Publications: 37

Kevin Marsh

Kevin Marsh

University of Oxford

Publications: 37

Carole A. Long

Carole A. Long

National Institutes of Health

Publications: 35

Something went wrong. Please try again later.